Meta Pixel

News and Announcements

The first bank to mint an Australian dollar stablecoin, the A$DC

  • Published May 19, 2022 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

We are pleased to share with you a collaboration that we are incredibly proud of.

Zerocap has underlined its position at the forefront of enabling and encouraging Australian investors and corporates to adopt and use digital assets and blockchain-based systems, with their involvement in A$DC, a stablecoin pilot project linked to the Australian dollar and backed by a major Australian bank.

Zerocap worked with ANZ Bank and global digital asset custody provider Fireblocks to mint A$DC, a new stablecoin pegged to the Australian dollar, for Victor Smorgon Group, a client of both ANZ and Zerocap. 

Register Interest

It is the first time an Australian bank has minted a digital asset linked to the value of the Australia dollar, and may be the first time a bank anywhere in the world has created a stablecoin that has been used in a real transaction.

Ryan McCall, Zerocap CEO and co-founder said:

“Most of the crypto industry has been focused on directly servicing the retail market, whereas we’ve invested from the outset in establishing the product, technology, compliance and team to properly service private and institutional clients, like the Victor Smorgon Group and ANZ. Digital assets are going mainstream; we’re thrilled to be at the forefront of driving adoption and bringing that vision to life.”

Read more in this AFR article here.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now